7 Tesla MR spectroscopy in diffusely infiltrating gliomas

• Conditions: C71.9; Brain, unspecified

• Registration Number: DRKS00003306
• Lead Sponsor: MR Exzellenzzentrum, Universitätsklinik für Radiodiagnostik, Medizinische Universität Wien

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2011-10-18
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

(in case of patients) radiologically verified brain tumor (diffus infiltrating glioma, WHO grade II-IV)
-(in case of patients) adequate performance score (Karnofsky score >70%)

Exclusion Criteria

-pregnancy
-any contraindications for MR imaging
-pacemaker
-(in case of volunteers) disease of the central nervous system (especially the brain)

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Development of an improved magnetic resonance spectroscopy sequence for 7 Tesla for three-dimensional metabolic mapping of pathologic brain areas.

Secondary Outcome Measures

Name	Time	Method
Successful clinical evaluation of developed 7 Tesla magnetic resonance spectroscopy method on brain tumor patients in comparison to healthy controls.